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The internill mammary atwy has become the preferred 
conduit for myocardiat revascularization because it has 
excellent long-term patency (t-3) and may result in im- 
proved p&km survival compared with that obtained with 
vein grafts (4.5). Vasospasm during isolation of the artery 
with its pedicle is common (6.7). In add&t. postoperative 
spasm of the mammary anety has been demonstrated 18). 
Treatment of vasosparm of the internal mammary anew not 
only may influence the decision regarding use of the artery as 
a graft. but also may improve the immediate flow in the &I 
ailer myocardial revascularization, 
The effect of vascdilators on mammary artery spasm has 
not been previously investigated. and it has not been deter- 
mined whether vawdilation f the artery will improve b&d 
Row when this artery is used tu a bypass graft. This study 
was designed to I) determine the effectiveness ofnitropms- 
side and nitmglycerin in inhibiling contraction of human 
internal mammary aneries studied in vitro, and 2) examine 
vasodilator drug effects on blood tlow in canine internal 
mammary artery and sapknaus vein grafts studied in v/w. 
M&ads 
obained from the Emory University operating room. The the same or different internal mammary arteries. Aiter the 
extra length of artery not used for coronary arlery grafting equilibration period, rings were contrneted with potassium 
was used in these studies. The experimental protocol was or norcpinephrinc. the contractile agent washed out and the 
submitted to the Human tnvestkmtions Commillee oi the tissues cquilibmted for an additional 20 to 30 min. This 
Emory University School of Medicine. and permission to 
WC these arterial scemcntr was rranted on the basis oi their 
being discarded sp&mens. Thesegments of internal mam- 
mary arteries were placed directly into lactated Ringer’s 
solution and tnnsPo&d to the laboratory. They were then 
immediately placed in oxygenated Krebs solution. cleansed 
of loose eonneetivc tissue and cut into 2.5 mm long rings. 
Two stainless steel wires were placed through the lumen of 
each tine: the rines were blaced in senwate muscle baths and 
one wir; was &nected’to an im&able support whereas 
the other wire was attached to a Grass Ff 0.03 force 
transducer. The time from collection in the operaling room 
to placement in the muscle bath was 45 min. Attention and 
exe were given to maintaining and not disrupting the integ- 
rity of the endothelium of each segment of artery. The 
presence of intact endothelium with this method of tissue 
prcparaion was demonstrated in orher audits (St. Isometric 
contractions were recorded on a Beckman Cynograph 
(Beckman Instrument Inc.) or a Grass model 5 polygraph 
(Grass Instrument Co.). The rings were equilibmted in the 
muscle baths in Krebs solution containing (in millimoler per 
liter): sodium chloride, 120; potassium chloride, 5.5; calcium 
chlande. 2.5; sodium bicarbonate. 20; dextrose, It; and 
calcium disodium ethylenediaminetetraacetatc, 0.029: 
gassed with 95% oxygen and 5% carbon dioxide and main- 
t&cd at 37°C. Rings were maintained at 1.5 g resting 
tension, which was determined to he optimal for maximal 
tension development in preliminary experiments. 
Eat I ring was equilibrated in Webs solution for approx- 
imatel. 30 to40 min with condnuour rcadiustment of restine 
tens& to 1.5 g. Rings were then contra&cd with either li 
m&:pc!sssium Krebs solution or IO pM norepinephrine. The 
70 n& potassium Krebs solution was made by equimolar 
substitution of potassium chloride for sodium chloride to 
bring the potassium concentration to 70 mM. Arteries eon- 
traeted with high wtalrsium wcrc incubated in Krebs solu- 
[inn containing I ,A4 phenlolamine IO block conttxtion 
caused by potassium-induced release of norepinephrine. In 
preliminary experiments. il was determined that 70 mM 
potassium and IO pM norepincphrine caused maximal con. 
traction of the human internal mammary artery. 
The vmodikmrs used were sodium nitroprusside and 
oitrodvcerin (American Critical Care). Stock solutions of 
sequenee’of contractile agent exposure and washout WBP 
repeated two to four times until stable and reproducible 
contractions were obtained. One ring from each segment of 
anery wan not exposed to vasodilator and served as a 
control, whereas the other rings were incubated with various 
vasodilators for 20 to 30 min. The rings were then exposed to 
twtassium or noreuinevhrine DIUE vsscdilator. and wak 
&action was r&wed. The contractile agent -was 
washed out and a higher concentration of vasodilator w 
added and allowed to equilibrate for 20 to 30 minutes. This 
sequence of eontraction, washout and vasodilator incubation 
was repeated for each conecntration of vasodilatar tested. 
Data analysis. The wntractile force of arterial rings not 
exposed to vasodilator was used as the control (100%) 
response. The contraction after expwre to vasodilator was 
compared with the parallel control eontraction to calculate 
the response as B percent of control. Dose-response curves 
were generated by plotting the percent ofcontrol cnntraction 
versus the log of concentmtion of varodilator. The mean 
EC,,, (effective concentration of vascdilator required for 
50% maximal inhibition of contra&n) war calculated for 
nitmprusside but not for nitmRlycerin because a large 
amcunt of nitroglycerin was needed to pmduce an effect. 
The data eolleetcd comprised five to six ring rezments fo: 
each inttervention. 
In Viva Canine fnf~r;.el Mammwy Artery and 
Saphenous Vein Grafts 
Pmwmtioa. E&t heartworm-free moncrct dws were 
used. ill animals r&eived humane care in &Pli&c with 
the Principles of Laboratory Animal Care set forth by the 
National Society for Medical Research and the Guide for the 
Care and Use of Labadory Animals prepared by the 
National Academy of Sciences and published by the Na- 
tional Institutes of Health tfittl Publication X8023. revised 
1978). The dogs were sedated and anesthetized with atphn- 
chlorolose (0.2 mg/kg) and urethane (2 g/kg). A cuffed 
endotracheal tube was inserted and ventilation was provided 
with a volume respirator. A canine right heart bypass 
preparation was established by way of a median sternotomy 
with cannulation of the right atrial appendage and right iliac 
vein for venous return. Arterial Row was orovided throuch 
the drugs (usually I mM) were preparch daily in 0.9% saline the pulmonary artery for right heart bypass and the lift 
solution. Stock solutions were diluted by IO. to I.OWfold subclavian and left femoral arteries for total heart byrasr. 
wilh Krcbs solution. In separate experiments. we deter. A saphenous vein dissected from the hind Ii& was 
mined that the nitmglycertn vehicle had no eRect on potas. anastomosed to the proximal ascending aona with a contin- 
sium or norepinephrine-induced contraction. uous monofilament suture. The right internal mammary 
Exprtmeahl protocol. The experiments were performed artery was dissected from the chest wall as a pedicle and its 
by simultaneously studying four to six ring segments from side branches clamped with metal clips. The animal was 
placed on total cardiopulmonary bypass but WF kept nor. 
mothermic. The hearl WBF then arrested with IOmllkg body 
weight of cold potassium cardloplegic soliltion (25 mEq 
KWliter. pH 7.81 after the appliczdnn of an sonic cross 
clamp. An end to ride anawmw~i~ was constructed from the 
vein graft o the proximal left anterior descending coronary 
artery with a contmuoos monofilament suture. The aorbc 
raw clamp was released and a recovery period allowed 
while the right internal mammarv artery was anastomoned to 
the distal portion of the vein graft in an end to side bsbion 
magnedc flow probe (Carolina Medical Electronics) pm.ced control Iegments mainmined relalively wnstant maximal fontrac- 
around the Proximal aspect of each graft. Flow was mea- dons with repeated potawun stimulations. Nitropmuide had sir+ 
sued through eachgrafc while the other wasclamped. In thin ilar potency for patassiumand rorepinephrinecontnctions. but was 
manner, both grafts &used the same coronary vascular 
\lighlly mwe cRectivc mmhibkin~ narepincpbrine-induced canlrac- 
bed. Care was taken not to clamp both grafts simultaneously 
,ion. 
to avoid reactive hyperemia. Aonic and left atrial pressures 
were measured through fluid-filled catheters insened mary artery and sapbenous vein graftr were compared. In 
thmugh a common ear&d arwy and a pulmonary vein. additmn, the pereen: change from control in graft Row and 
respectively. and monitored with Hewlett-Packard quartz hemodynamics was calculated and compared for each drug. 
prextre transducers. Leh ventricular oressure and its first All comoarisonr were made usine the Student’s I test for 
derivative were monitored with a Mikn&p pressure traos- paired differences and considered slatistically rigni8caa.t 
ducer (Millar Instruments) inserted through the left vcnlri. when D < 0.05. 
cular aoex and secured with a aledeeted s&e. A8 erasure 
and b&d Row recordingr rerc mlde on a Hwl;t&xkard 
77588 multichannel recorder (Hewlett-Packard Medical 
Flertmnird -._ .. _.__, 
Cardiac ourpnr was kept corw~nrdt IO0 ml/kg per min by Contractile rrrpaar to Pdassiam and wnpittepbriw. 
right heart byPa with infusion of blood into the pulmcnsry Control segments of internal mammary artery oat exposed 10 
artery. Blcmd pressure was kept constant by systemic arte- nsodilator dogs maintained relatively consistent maximal 
rial blood infusion or withdrawal. Heart rate was abo contractions with repeated potassium stimulation (Fig. II. 
maintained constant by attial pacing when needed. PaO,. The maximal contractile response elicited by 70 mM of 
PaCO, and pH were maintained within normal Iunits potassium chloride produced a mean peak contraction of 
throughout the experimental procedure. Hematocrit was 2.505 r 300 mg (based an mea~orement~ iii al least five 
maintained at 25%. 
Expeeimmtat pmtocd. The drugs were given in random 
order by continuous infusion through the left atrium. The 
vasodilator drugs selected were those that are commonly 
used after cardiac operations, namely. nitroglycerin II &kg 
per min) and nitroprusside (I &kg pr min). Control mea- 
serentent~ of bled Row and hemodynamic variables were 
xpeated before each drug adminirtrarion. Each pharmaco- 
logic intervention was etTected al5 min before measure- 
segments). Higher potassium concentrations did not in- 
crease the maximal contractile responz. After washout of 
the potwium Krebs solution. arterial rings, relaxed to the 
initial baseline tension. 
NorPpi,7Pphri,le-;nd,,=~d eonrraerions were less consist- 
ent than those caused by potassium and usually resulted m a 
progressive decrease in contraction with repealed stimula- 
tion. The rnaximal decreax in norepineFhn’ne-induced con- 
traction of control arterial samems averaged 24 t 6%. Ten 
&t. In addition. a rest interval of 10 min was allowed micromolra of norepinephriie produced i mean peak con- 
between each intervention. All heowdynamic veriabler were traction of 2.835 -+ 410 mg. 
held con~tant o isolate the eiTect of vascdilator drugs on Vasedilator iaMbiHan d potassium contraethw. A dose- 
graft now. response curve for nitroprusside-induced inhibition ofpatas- 
Stalistical analysis. The effect of each drug on craft Row wm contnc:~on is shown in Figure I. Nitmprusside was not 
and hemodynamies was compared with co& &wre- potent but wa:, more potent than nitroglycerbt. which inhib- 
mats in each graft ad the rerpooses of the internal mam- ited polarrium-induced contraction only at high doses tlCQ 
Tabk 1. Relavanl Effecta al Vaaodilators on Potasrium- and 
Norepincphrine-induced Contra&n of Human Mammary 
Ancry Scgmcnts -- 
Marlmal w 
EC,, wfi lnbibilion 
Vvcdilator K NE K NE 
Nitroprurride 0.302 0.447 55 t 7 71 f 8 
(coti to 0.380, 10.190 lo O.S%I 
?aroglyecrin - ID 2 8 56 f 5 
ti. At maxim& effective dascs of vasodilator. nitroorus- 
iid; was slighlly I&C elk&e than was nitroglycerin (55 2 
7% versus 30 + 8% respectively) (Table I). 
Vasodilator inhibItinn at wrepiuepbrine contraction. The 
abilily of sodium nitmprusside :O inhibit norepinephriue 
contra&n was similar to ils abiliry to inhibh polasaium- 
induced conlraction. Nitroglycerin was again not a pooteut 
inhibihx of norepinephrine contraction. Both nitroprusside 
and nitroglycerin were more effective in inhibiting norepi- 
nephrine contraction than potassium-induced contraclion 
(Table I). Nitroprusside was more effective in inhibiting 
oorepincphtine-induced contraction rhan was nitroglycerin 
(11 f 8% versu5 56 r 5%, respectively). 
In Viva Canine Internal Marnmury Artcry 
Hemodynamic effects of drug administration in the eight 
dogs are demonstrated in Table 2. Vasodilator drug effects 
on blood flow in the canine inkmal mammary artery graft 
and saphenous vein grafl are demonstrated in Table 3. 
Nitroprasside. Admizlistration of nitmprusside II I &kg 
per min did no, alkr hemodynamic measurements. Flow 
decreased in the mammary artery graft from 50 z 7 IO 44 2 
7 mUmin (p < 0.005) but increased in the saphenans vein 
graft from64 f 4 to77 C 7 mlimin (p < O.O05l(Fig. 2). A -12 
f 2% decrease was seen in intenal mammary artery graft 
flow whereas a 25 k 8% increase was seen in saphenous vein 
graft flow (Fig. 3). The decrease in mammary graft Raw was 
significantly different from the increase in saphenous graft 
flow (p < 0.0025). 
Nitroglycwin. All variables except graft Row were on- 
changed with nitroglycerin infusion at 1 &kg peer min. 
Variations in flow were seen in different animals. but each 
animal responded similarly to drug administration (Fig. 2). 
Flow in the internal mammary anery graft increased signif- 
icantly from 42 k 7 to 59 L 7 mlimin (p < 0.0025) whereas 
flow decreased significantly in the saphenous vein graft from 
69 r 4 IO 59 f 8 mllmin (p < 0.0005). The 36 + 13% increase 
in mammary artery graft Row was significantly d&rent from 
the -14 * 3% change in saphenous vein graft flow (p i 
0.005) (Fig. 3). 
Discussion 
Myocardial revascularization is a common and effective 
treatment of coronary artery disease. APhough the saphe- 
nous vein is usually used for grafting (lO,ll), the internal 
mammary artery has recently gained recognition as a conduit 
(l-3). The artery is less prone to develop arteriosclerosis f 12) 
and has demonstrated superior long-term patency (l-3). 
Some investigators (4.5) have also claimed that it results in 
better patient survival. Techniques have recently been de- 
scribed (13.14) to revascularize large areas of myocardium 
with the mammary artery to expand its utilization as a 
conduit. Accordingly, the internal mammary artery is cur- 
rently the preferred conduit for myocardiil revasculariza- 
tion. 
Role uf spasm in the internal mammary artery. The inter- 
nal mammary artery is a vasoactive vessel (15,M). Recenl 
studies (8,15,17) have suggested that the artery can enlarge 
with lime lo meet Ihe demands ofthe coronary vascular bed. 
Vawspasm of the inlemal mammary arkry during its isola- 
tion fmm the chest wall is frequently seen (67). In addition. 
vanospasm has been seen poEtoperatively (8). Treatmenl of 
vasospasm not only may influence the decision regarding use 
Table 2. Hetnodyntic EiTcctx OT Varodilator Drug Adminirlnrion in Eight Dogs 
of the artery as a graft, but also may improve Row through 
this graft postoperatively. Some studies (6.7) have wed 
mechanical dilation of the internal mammary artery to re- 
verse vanospssm (6,7): however. mechanical dilation can 
cause intimal damage. which may lead 1’1 thrombosis or 
obstruction to Row in the graft. or both (6.18). In addition, 
endotheliel cell damage may enhance arterial soasm or 
constriction of the iotemal m&ornery artery by iedt& the 
formation of eodothelial derived relaxing factors (19). Topi- 
cal ppaverine has been used to reverse mammary artery 
spasm (6,18), but other vasodilators have not been investi- 
gated. 
Our in vitro method W(IS chosen 10 evaluate rbe ability of 
two commonly used vasodilarors to inhibit corrrmcrion of#w 
human infernal nmmmory aav-y. Because the mechanisms 
of spasm of this artery are oat known. two e~eots were used 
to induce contraction by different mechao&ts with both 
extracellular and inlmcellular calcium pals. Potassium cott- 
tmcts voscolar smooth moscle by direct membrane depolar- 
ization, resulting in an influx ofentracellularcalcium (20.21). 
whereas txxepinephrioe is thought to case contraction of 
vascular smooth muscle by stimulating alpheodrenergic 
receptors, which caose release of intmcellular calcium 
C20,Zl) m-d some influx of extracellular calcium iirroqh 
receptor-operated calcium channels (21). Both agettt~ were 
used in this stody to evaluate both mechanisms of arterial 
contraction. 
F&we 2. Venodilator dreg effect on blood Row in int~mal mam- 
maw enery IIMA) gnR in eight dqs. individual Sows are depicted 
by Suet and mean SW + SEM is represented by circlee a trirngks. 
Although there are wide variations in flow among dii?erent aoiotalr. 
each animal rerponded similarly to vascdilator admioirtntion. Ni- 
troprosside itrim&) decreased internal mammary artery Sow 
whereas nitroglycerin WW sigoificandy increased it. 
The role of rhe endothelium in arreriul conrmcrion has 
recenrly been emphasized (22.23). Our stodv utilized a 
method of tissue preparation that prexrve~ the integrity of 
the endothelium. Although we did not soecificallv test for :he 
presence of endothelium, other studie~olilizing~an identical 
method of tissue preparatioo have demonsln.ted its presence 
19.22.24). In addition, the nitrates have been found to be 
endothelium-independent vasodiloton (22.25.26). The pres- 
ence or akcnce of eodothelium should therefore not affect 
our results with the vaaodilators used. 
Inhibition of mammary artery cotttrnabn by vssodi$tors. 
Nitmprosside and nitroglycerin relax various somoth mos- 
cles including vascular, uterine. gastrointestinal and brow- 
chiel. The mechanism of action of these dtttgs ott voxolar 
smooth moscle appears to require reaction with a sulfhydryl 
mooo. which results in the lowetine of intracellular calcium 
?27L’Recent studies (26.28) have fo&d increased intracelia- 
lar levels of cyclic guanosine monophosphate (GMP) in- 
duced by oitropmsside and nitroglycerin, which may be 
responsible for their vasodilamr effect. Our study found 
nitroprosside to be more potent and more effective than 
nitm&wbt in inhibiting contraction of the human internal 
mammary artery. Nilroprunnide had inhibited potassium and 
mrrepinephrine contraction at similar dose ievels. Both 
Fire 3. The pment change in graft blaal Row compared With 
coetmf is demonstrated. The internal mammary ancry tIMAt is 
reprewtted by opn bars and the wrphewos vein graft WO) is 
represented by tlDdXd hers. The opposite elect ofeitrcatycerin and 
nitropmrride on graft blmd Row car, be apprrc;?ted. 
nitroprusride and niimglyccrin were more effective in in- muscular arteries (42). The internal msmmary artery conduit 
hibiting norepinephrioe-induced than potassium-indoccd has more resistance to Row than does the saphenous van 
cootractioo. Previous studier (291 have also shown that 133). as demonstrated by its lower control blood flow. Any 
nitroprusside i; more effective in relaxing norepinephrine- vasodilntion of the mammary artery would therefore result in 
contracted arteries. pmbably because its vasodilator mech- an increase in graft Row. which was evidenced. A decrease 
anism of action depends more on inlracellular than on in saphenous vein graft Raw has also been observed with 
extracellular calcium. nitroglycerin in some clinical studies (43.44). The diminished 
EtTees of vasodilstors on mammary artery and saphenoos graft Row probably results from nitroglycerin-induced in- 
vein graft Row. The next portion of this study assessed crease in collateral coronary blood flow to the area perfused 
whether inhibition of contraction of the mammary artery by by the graft (45) resulting in competing Row to that area with 
vasodilators studied in vitro could be correlated with alter- decrease in vein graft Row. The vasodilalion of the mam- 
ations in blood Row in canine mammary artery grafts studied mary artery evidently was greater than its competitive 
in viva. We selected our in viva canine model instead of an collateral flow and thereby resulted in a net increase in grait 
in viva human model to more effectively maintain constant flow. Although rghenoos win graft flow war dxreased by 
sysslemic hemodynamic voriabkr. Prior stu:;es (30-32) have nitroglycerin, myocardial blood Row to the area might have 
evaluated internal mammary artery waft Row. but our study increased. Favorable effects on mvocardial metabolism with 
mom ellectively isolated the local &ect of the drugs fro& 
their systemic effects. In thts model. graft Row is dependent 
not only on the effect of the drug on the conduit (mammary 
artcry and saphenous vein). but also on the effect of the drug 
on the associated regional vascuIature. corooary as well as 
sub&&m. The saphenour vein was chosen as a conduit as 
well because it is most commonlv used for eroftina and 
shou!d be less vosoreactive than the mammary&tery~33). 
shunted blood flow away from the mammary branch of the 
Nitropmssidc ~ersos nitroglycerio e5ects. Nilropmsside 
decreased graft Row in the co&e internal mamma& artery 
whereas it increased graft Row in the ssphenous vein. 
subciavian anery and thereby resulted in a decrease in 
Nitroorosside is mainlv art arteriolar vasodilatorand has less 
effect on collateral &Is (341 and large coronary arteties 
mammary artery Row. Alternatively, with marked coronary 
(35.36). The coronary arteriolar vasodilation resulted in an 
increase in aphenous vein gnft flow. Other studies (37) 
vasodilation. the resultant decrease in pressure along the 
have similarly demonstrated increased raphenous vein graft 
flow with nitroprosride administration. Decreased Row in 
the internal mammary artery was unexpected and was pr- 
haps due to peripheral arteriolar vasodilation of the rerper- 
Live suhclavian and brachial arteries. This would have 
nitroglycerin administration have been observed after aorto. 
coronary bypass operations (38). Only wail flow was mea- 
sured inthis study,.but regional royo&r&l blood flow to the 
area supplied by the grofr merits investigation. 
been-seen possibly BE a result of blood-home factors or 
experiment?1 conditions (4748). 
h vqro humam data wrsos ennine graft data. These 
divergent results with the in vitro human data and in viva 
An alternative explanation for the divergent in vitro and 
canine data are surprising. The most effective agent in 
inhibiting inlemal mammary artery contraction would have 
in viva results may be soecies variatkm (49). Most of the 
been vxpected to cause a greater increase in arterial flow. 
Close correlation between in vitro and in viva vascular 
reactivity has been shown in rewoose to some drugs but not 
to “then (46). These unexp&ed data may ha”; resul!ed 
from the effect of the drag on the associated regional 
vasculaiure: coronary and collateral versus subclavian and 
brochial arteries. More marked vasodilation by nitroprw 
side, as seen in human in vitro studies, may have resulted in 
brocbial or subclavian vasodilation with a steal away from 
the internal mammary artery and a resultant decrease in 
canine in viva mamtnary artery blood flow. In addition, 
divergent results between in vitro and in viva studies have 
mammary artery might have resulted in an increased conduit 
resistance, thereby reducing mammary ancry Row. Nitro. 
prosside administration after coronary artery surgery has 
also been arsociatcd with a decrease in myocardial lactate 
extraction, which may represent regional myocardial ische- 
mia (381. 
Nifmglyrcrin prod!rrcd rcrrd/s uppo-pu)il~ to rbore xcct~ 
wirlr ~rimprusside. Graft How increased in the internal 
mammary artery but decreased in the saphenous win graft 
with nitroglycerin administration. Nitroglycerin has been 
shown to he a potent woodilator and a mild arteriolar 
vavzdilator 139). It act& mainly on the lnrgcr conductive 
anerics and collateral VCSECIS (3+36.40.41). Nitroglycerin 
dccrcasen voscUlar resistwce in coronary. cwaneous and 
reported species v&ions have oxur:ed with contractile 
agents (50). Thus. acelylcholine was reported (51) to coo- 
twt human coronary aneries but to relax canine coronary 
arteries with intact endolhelium; species diiierences with 
vosodilators have not been mentioned. A maximal percem 
inhibition of potassium and norepinephrinr contraction in 
canine renal arteries (291 similar to that of our data of human 
mammary arteries has been reported. I1 is therefore unlikely 
that species variations between the human and canine mam- 
mary artery account for our results. Our study utilized the 
canine model in viva to more effectively isolate the effect of 
the vasodilators oo graft Row independent of systemic and 
cardiac hemodynamics. However, in viva studies in canine 
vessels do not necessarily predict the in viva response of 
human vessels. To directly apply the canine in viva data m 
humans, similar in vitro studies need to be performed on 
canine mammary arteries; these are currently in progress. 
Conclusions. Our results demonntrare that. although so- 
dium nitropmsside is more e&ctive in inbibbing ~nwnnl 
mammary artery conlraction in vitro. it decreased msmmary 
BAW graft Row measured in viva. Nitroglycerin had the 
opposite effect with an increase in mammary anery graft 
flow. Vasodilator drug effects on r:nw in saphenow van 
grafts were different from those in internal eammar~ ,trtery 
grafts: saphenous vein graft Row increazd with nitropms- 
side but decreased with nitroglycerin. The WSCL!BI reactiv- 
ity of the internal mammary artery and regional vascuia:ore 
must therefore be considered when vasodilator drugs are 
used after coronary revascularizarion. 

